Ganjapreneur: University of Cincinnati offering cannabis studies certificate program

UC launches program that covers cannabis history, culture, society and regulatory topics

The University of Cincinnati is among the first universities to offer a certificate in cannabis studies. 

A News Record article about the unique program was picked up by Ganjapreneur, an online medium for cannabis industry news.

The certificate is offered through the horticulture program in the College of Design, Art, Architecture, Art and Planning (DAAP)'s School of Planning as a response to an increasing need for knowledgeable graduates familiar with cannabis as the industry becomes more mainstream. It offers students a multi-disciplinary foundation for understanding the cannabis plant and the cannabis industry, enabling them to more readily gain employment in one of its many subfields.

Learn more about cannabis studies at UC.

Read the full story in Ganjapeneur.

 

Featured image at top: Wikimedia Commons

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

Is going nuclear the solution to Ohio’s energy costs?

November 10, 2025

The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.

3

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.